Impact of opioid use on patients undergoing screening colonoscopy according to the quality of bowel preparation

by Lois Lamerato, Eric Wittbrodt, Manpreet Kaur, Catherine Datto, Sumit Singla
Published 2020-06-01

Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collabo...

by Eric Wittbrodt, Narinder Bhalla, Karolina Andersson Sundell, Qi Gao, Liyan Dong, Matthew A. Cavender, Phillip Hunt, Nathan D. Wong, Carl Mellström
Published 2020-07-01

Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagemen...

by Julie C Lauffenburger, Roya Ghazinouri, Saira Jan, Sagar Makanji, Christina A Ferro, Jennifer Lewey, Eric Wittbrodt, Jessica Lee, Nancy Haff, Constance P Fontanet, Niteesh K Choudhry
Published 2019-01-01

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

by Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, Shun Kohsaka, Carolyn S. P. Lam, Su-Yen Goh, Chern-En Chiang, Jonathan E. Shaw, Matthew A. Cavender, Navdeep Tangri, Josep Franch-Nadal, Reinhard W. Holl, Marit E. Jørgensen, Anna Norhammar, Johan G. Eriksson, Francesco Zaccardi, Avraham Karasik, Dianna J. Magliano, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip Surmont, Peter Fenici, the CVD-REAL Investigators and Study Group
Published 2021-07-01